Sign in
Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury : results of two phase III clinical trials
Journal article   Peer reviewed

Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury : results of two phase III clinical trials

G. F MORRIS, R BULLOCK, S. B MARSHALL, A MARMAROU, A MAAS and L. F MARSHALL
Journal of neurosurgery, Vol.91(5), pp.737-743
1999
PMID: 10541229

Abstract

Biological and medical sciences Neuroprotective agent Medical sciences Neuropharmacology Pharmacology. Drug treatments

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.134 Trauma & Emergency Surgery
1.134.286 Traumatic Brain Injury
Web Of Science research areas
Clinical Neurology
Surgery
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details